Basic Information
| LncRNA/CircRNA Name | PTENPL |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Luciferase reporter assay etc |
| Sample | bladder cancer tissues compared with normal tissues, cell lines (J82,T24, SV-HUC-1) |
| Expression Pattern | down-regulated |
| Function Description | The PTENP1/miR-20a/PTEN axis was involved in the progression of bladder cancer. Our study investigated the function of miR-20a in bladder cancer and provided new insights into the treatment of bladder cancer. |
| Pubmed ID | 32271413 |
| Year | 2020 |
| Title | MiR-20a Acted as a ceRNA of lncRNA PTENPL and Promoted Bladder Cancer Cell Proliferation and Migration by Regulating PDCD4 |
External Links
| Links for PTENPL | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |